Indian-origin CEO's startup raises $1 billion from SoftBank
US-based biopharmaceutical startup Roivant Sciences, founded by Indian-origin entrepreneur Vivek Ramaswamy, has raised $1.1 billion led by SoftBank Vision Fund. Roivant identifies drugs that other pharmaceutical and biotech companies may have stopped advancing and aims at developing those medicines through its subsidiaries. The funding is one of the largest for a health tech startup.